Corcept Therapeutics Incorporated Stock Forecast

NASDAQ:CORT Open Broker Account

$25.05 (0.502%)

Volume: 185.485k

Closed: Dec 02, 2022

Hollow Logo Score: 1.578

Corcept Therapeutics Incorporated Stock Forecast

$25.05 (0.502%)

Volume: 185.485k

Closed: Dec 02, 2022

Score Hollow Logo 1.578

Corcept Therapeutics Incorporated Stock Statistics NASDAQ:CORT

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-02 - 2022-12-02 BUY 0
2022-11-29 - 2022-12-02 SELL -1.88
2022-11-28 - 2022-11-29 BUY 0.710
2022-11-17 - 2022-11-28 SELL -2.39
2022-11-14 - 2022-11-17 HOLD -0.593

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE